• Latest Posts

Animal-free milk company Imagindairy reaches $28M in funding

Duke Street Bio enters stage with next-generation cancer therapies

Vaccines mobilized to control monkeypox outbreak

In Depth 23 May 2022

The coming of age of European synthetic biology

Zealand Pharma’s drug for rare metabolic disease smashes phase III

ADVERTISEMENT

Evotec, Sernova in partnership to develop beta cell diabetes therapy

F2G enlists Shionogi to bring antifungal treatment to Europe and Asia

US Giant Apollo Bags Billion-Euro Partnership with Sofinnova

Valneva’s Covid-19 Vaccine Contract in Dire Straits as EU Approval Lags

Opinion 16 May 2022

CRISPR Can Help The Switch To Sustainable Cosmetics

ADVERTISEMENT